{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:52:32Z","timestamp":1785455552400,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Roughly 10 -15% of global populace suffer from Chronic Kidney Disease(CKD). A major secondary disease that can progress to end-stage renal disease (ESRD) is obesity-associated kidney disease (ORG). Although clinical management strategies are currently available, morbidity and mortality rates are increasing. Thus, new solutions are needed. Intestinal permeability, systemic inflammation, and aberrant intestinal metabolites have all been linked to ORG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>ACT001 has anti-inflammatory, redox-regulatory and antitumour activities. The current study was designed to examine how ACT001 affects ORG and analyze the fundamental processes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A high-fat diet (HFD) was used to generate ORG in female C57BL\/6\u00a0J mice.<\/jats:p>\n                <jats:p>ORG mice were divided into three groups at random:\u00a0HFD, HFD\u2009+\u2009ACT001, HFD\u2009+\u2009polyphosphocholine (PPC). To assess renal and colonic damage, periodic acid-Schiff (PAS) and hematoxylin\u2013eosin (HE) staining were used. Following that, renal inflammation, oxidative stress, lipid deposition, colonic inflammation, and intestinal permeability were evaluated by protein blotting, polymerase chain reaction (PCR), immunohistochemistry, and immunofluorescence staining. Lastly, the SCFAs content was assessed by gas chromatographymass spectrometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mice in the HFD group displayed more severe albuminuria, glomerular hypertrophy, renal oxidative damage, inflammation, and lipid accumulation than mice with the normal diet (ND) group, as well as lower levels of intestinal SCFA valproic acid, colonic inflammation, and tight junction protein downregulation. ACT001 treatment restores the content of valproic acid in intestinal SCFAs, promotes the binding of SCFAs to renal GPR43, activates the AMPK signalling pathway. Therefore, it promotes the Nrf2-Keap1 signalling pathway and inhibits the NF-\u03baB signalling pathway. SCFAs, additionally, augment colonic GPR43 concentrations, diminishing NLRP3 inflammasome expression and restoring ZO-1 and occludin protein levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study is the first to look at ACT001's potential as a treatment for obesity-related kidney disease. Regulating GPR43 and AMPK signalling pathways, By controlling the GPR43 and AMPK signalling pathways, ACT001 improves colitis and the intestinal mucosal barrier, decreases renal lipid deposition, and suppresses inflammation and oxidative stress in the kidneys.\u00a0According to this study, ACT001 could be a viable ORG therapy option.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01949-2","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:10:58Z","timestamp":1700284258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43\/AMPK pathway"],"prefix":"10.1186","volume":"22","author":[{"given":"Yibing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"1949_CR1","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"D-Q Sun","year":"2021","unstructured":"Sun D-Q, Jin Y, Wang T-Y, Zheng KI, Rios RS, Zhang H-Y, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433.","journal-title":"Metabolism"},{"issue":"8","key":"1949_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D'Agati","year":"2016","unstructured":"D\u2019Agati VD, Chagnac A, de Vries APJ, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453\u201371.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1949_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMe1706095","volume":"377","author":"EW Gregg","year":"2017","unstructured":"Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377(1):80\u20131.","journal-title":"N Engl J Med"},{"key":"1949_CR4","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.2147\/DMSO.S334199","volume":"14","author":"L Wei","year":"2021","unstructured":"Wei L, Li Y, Yu Y, Xu M, Chen H, Li L, et al. Obesity-related Glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes. 2021;14:4371\u201380.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1949_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/0886022X.2018.1450763","volume":"40","author":"Z Wang","year":"2018","unstructured":"Wang Z, Huang W, Li H, Tang L, Sun H, Liu Q, et al. Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats. Ren Fail. 2018;40(1):175\u201382.","journal-title":"Ren Fail"},{"issue":"7","key":"1949_CR6","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1194\/jlr.M076216","volume":"58","author":"P Yang","year":"2017","unstructured":"Yang P, Xiao Y, Luo X, Zhao Y, Zhao L, Wang Y, et al. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J Lipid Res. 2017;58(7):1417\u201327.","journal-title":"J Lipid Res"},{"issue":"12","key":"1949_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneph.2009.184","volume":"5","author":"XZ Ruan","year":"2009","unstructured":"Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713\u201321.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"1949_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"APJ de Vries","year":"2014","unstructured":"de Vries APJ, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1949_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2018.06.012","volume":"134","author":"GJ Weber","year":"2018","unstructured":"Weber GJ, Foster J, Pushpakumar SB, Sen U. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation. Pharmacol Res. 2018;134:157\u201365.","journal-title":"Pharmacol Res"},{"issue":"17","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.3390\/ijms22179641","volume":"22","author":"A Zaky","year":"2021","unstructured":"Zaky A, Glastras SJ, Wong MYW, Pollock CA, Saad S. The role of the gut microbiome in diabetes and obesity-related kidney disease. Int J Mol Sci. 2021;22(17):9641. https:\/\/doi.org\/10.3390\/ijms22179641.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1949_CR11","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312\u20139.","journal-title":"J Biol Chem"},{"issue":"16","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1039\/D3FO01257C","volume":"14","author":"V Naval\u00f3n-Monllor","year":"2023","unstructured":"Naval\u00f3n-Monllor V, Soriano-Roman\u00ed L, Silva M, Hazas Las, de MCL, Hernando-Quintana N, Su\u00e1rez Di\u00e9guez T, et al. Microbiota dysbiosis caused by dietetic patterns as a promoter of Alzheimer\u2019s disease through metabolic syndrome mechanisms. Food Funct. 2023;14(16):7317\u201334.","journal-title":"Food Funct"},{"issue":"3","key":"1949_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230\u20137.","journal-title":"Am J Nephrol"},{"key":"1949_CR14","doi-asserted-by":"publisher","first-page":"1896781","DOI":"10.1155\/2022\/1896781","volume":"2022","author":"C Ji","year":"2022","unstructured":"Ji C, Lu F, Wu Y, Lu Z, Mo Y, Han L, et al. Rhubarb Enema Increasing Short-Chain Fatty acids that improves the intestinal Barrier disruption in CKD may be related to the regulation of Gut Dysbiosis. Biomed Res Int. 2022;2022:1896781.","journal-title":"Biomed Res Int"},{"issue":"10","key":"1949_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","volume":"10","author":"X Xi","year":"2019","unstructured":"Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y, et al. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma. Cell Death Dis. 2019;10(10):757.","journal-title":"Cell Death Dis"},{"key":"1949_CR16","doi-asserted-by":"publisher","first-page":"108944","DOI":"10.1016\/j.intimp.2022.108944","volume":"110","author":"H Guo","year":"2022","unstructured":"Guo H, Song Y, Li F, Fan Y, Li Y, Zhang C, et al. ACT001 suppressing M1 polarization against inflammation via NF-\u03baB and STAT1 signaling pathways alleviates acute lung injury in mice. Int Immunopharmacol. 2022;110:108944.","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"1949_CR17","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10(13):5943\u201356. https:\/\/doi.org\/10.7150\/thno.41498.","journal-title":"Theranostics"},{"issue":"1","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-022-00862-y","volume":"20","author":"L Cai","year":"2022","unstructured":"Cai L, Gong Q, Qi L, Xu T, Suo Q, Li X, et al. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NF\u03baB\/NLRP3 pathway. Cell Commun Signal. 2022;20(1):56.","journal-title":"Cell Commun Signal"},{"key":"1949_CR19","doi-asserted-by":"publisher","first-page":"114808","DOI":"10.1016\/j.biopha.2023.114808","volume":"163","author":"H Luo","year":"2023","unstructured":"Luo H, Liu X, Liu H, Wang Y, Xu K, Li J, et al. ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed Pharmacother. 2023;163:114808.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1949_CR20","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1038\/s41598-023-38448-4","volume":"13","author":"H Zhou","year":"2023","unstructured":"Zhou H, Niu B, Wu X, Chu W, Zhou Y, Chen Z, et al. iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice. Sci Rep. 2023;13(1):11336.","journal-title":"Sci Rep"},{"issue":"23","key":"1949_CR21","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.3390\/nu14234945","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Xiao Y, Huang Y, Song L, Li M, Ren Z. Lactobacillus gasseri RW2014 ameliorates hyperlipidemia by modulating bile acid metabolism and gut microbiota composition in rats. Nutrients. 2022;14(23):4945. https:\/\/doi.org\/10.3390\/nu14234945.","journal-title":"Nutrients"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","volume":"13","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, et al. The AMPK pathway in fatty liver disease. Front Physiol. 2022;13:970292.","journal-title":"Front Physiol"},{"issue":"2","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jphs.2020.02.009","volume":"143","author":"L Chen","year":"2020","unstructured":"Chen L, Li L, Han Y, Lv B, Zou S, Yu Q. Tong-fu-li-fei decoction exerts a protective effect on intestinal barrier of sepsis in rats through upregulating ZO-1\/occludin\/claudin-1 expression. J Pharmacol Sci. 2020;143(2):89\u201396.","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091\u2013103.","journal-title":"Gut"},{"issue":"6","key":"1949_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1681\/ASN.2019101029","volume":"31","author":"YJ Li","year":"2020","unstructured":"Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, et al. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31(6):1267\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"50","key":"1949_CR26","doi-asserted-by":"publisher","first-page":"13133","DOI":"10.1021\/acs.jafc.8b03942","volume":"66","author":"H Cao","year":"2018","unstructured":"Cao H, Liu J, Shen P, Cai J, Han Y, Zhu K, et al. Protective effect of Naringin on DSS-Induced Ulcerative Colitis in mice. J Agric Food Chem. 2018;66(50):13133\u201340.","journal-title":"J Agric Food Chem"},{"key":"1949_CR27","doi-asserted-by":"publisher","first-page":"116215","DOI":"10.1016\/j.jep.2023.116215","volume":"308","author":"Z Li","year":"2023","unstructured":"Li Z, Song Y, Xu W, Chen J, Zhou R, Yang M, et al. Pulsatilla chinensis saponins improve SCFAs regulating GPR43-NLRP3 signaling pathway in the treatment of ulcerative colitis. J Ethnopharmacol. 2023;308:116215.","journal-title":"J Ethnopharmacol"},{"key":"1949_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","volume":"4","author":"I Kimura","year":"2013","unstructured":"Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.","journal-title":"Nat Commun"},{"issue":"4","key":"1949_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/cells11040750","volume":"11","author":"S Al Mahri","year":"2022","unstructured":"Al Mahri S, Malik SS, Al Ibrahim M, Haji E, Dairi G, Mohammad S. Free Fatty Acid Receptors (FFARs) in adipose: physiological role and therapeutic outlook. Cells. 2022;11(4):750. https:\/\/doi.org\/10.3390\/cells11040750.","journal-title":"Cells"},{"issue":"1","key":"1949_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40168-023-01648-1","volume":"11","author":"X Zeng","year":"2023","unstructured":"Zeng X, Li J, Shan W, Lai Z, Zuo Z. Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome. 2023;11(1):204.","journal-title":"Microbiome"},{"key":"1949_CR31","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.abb.2019.07.022","volume":"672","author":"H Yoshida","year":"2019","unstructured":"Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43\/AMPK signaling pathway. Arch Biochem Biophys. 2019;672:108057.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1949_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/JOE-20-0018","volume":"245","author":"M Deng","year":"2020","unstructured":"Deng M, Qu F, Chen L, Liu C, Zhang M, Ren F, et al. SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD. J Endocrinol. 2020;245(3):425\u201337.","journal-title":"J Endocrinol"},{"issue":"21","key":"1949_CR33","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.3390\/ijms21217994","volume":"21","author":"F Juszczak","year":"2020","unstructured":"Juszczak F, Caron N, Mathew AV, Decl\u00e8ves AE. Critical role for AMPK in metabolic disease-induced chronic kidney disease. Int J Mol Sci. 2020;21(21):7994. https:\/\/doi.org\/10.3390\/ijms21217994.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1949_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ki.2013.462","volume":"85","author":"A-E Decl\u00e8ves","year":"2014","unstructured":"Decl\u00e8ves A-E, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, et al. Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int. 2014;85(3):611\u201323.","journal-title":"Kidney Int"},{"key":"1949_CR35","doi-asserted-by":"publisher","unstructured":"Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, et al. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. mBio. 2017;8(3):e00470\u201317. https:\/\/doi.org\/10.1128\/mBio.00470-17. Erratum in: MBio. 2017;8(4).","DOI":"10.1128\/mBio.00470-17"},{"key":"1949_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.02.039","volume":"198","author":"Y-P Guo","year":"2018","unstructured":"Guo Y-P, Jiang H-K, Jiang H, Tian H-Y, Li L. Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-\u03baB and ERK\/p38 MAPK-dependent inflammation. Life Sci. 2018;198:112\u20138.","journal-title":"Life Sci"},{"key":"1949_CR37","doi-asserted-by":"publisher","first-page":"9734560","DOI":"10.1155\/2020\/9734560","volume":"2020","author":"X Ding","year":"2020","unstructured":"Ding X, Jian T, Li J, Lv H, Tong B, Li J, et al. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK\/Nrf2\/NF\u03baB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice. Oxid Med Cell Longev. 2020;2020:9734560.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"1949_CR38","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1172\/JCI66218","volume":"123","author":"LL Dugan","year":"2013","unstructured":"Dugan LL, You Y-H, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves A-E, et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest. 2013;123(11):4888\u201399.","journal-title":"J Clin Invest"},{"issue":"2","key":"1949_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209\u201312.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1949_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1681\/ASN.2009060615","volume":"22","author":"S Lee","year":"2011","unstructured":"Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi B-S, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22(2):317\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1949_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00424-023-02799-8","volume":"475","author":"PN Prem","year":"2023","unstructured":"Prem PN, Chellappan DR, Kurian GA. High-fat diet-induced mitochondrial dysfunction is associated with loss of protection from ischemic preconditioning in renal ischemia reperfusion. Pflugers Arch. 2023;475(5):637\u201353.","journal-title":"Pflugers Arch"},{"issue":"10","key":"1949_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629\u201346.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1949_CR43","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83(6):1029\u201341.","journal-title":"Kidney Int"},{"issue":"9","key":"1949_CR44","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/biom12091227","volume":"12","author":"DM Tanase","year":"2022","unstructured":"Tanase DM, Gosav EM, Anton MI, Floria M, Seritean Isac PN, Hurjui LL, et al. Oxidative stress and NRF2\/KEAP1\/ARE pathway in Diabetic Kidney Disease (DKD): new perspectives. Biomolecules. 2022;12(9):1227. https:\/\/doi.org\/10.3390\/biom12091227.","journal-title":"Biomolecules"},{"issue":"Pt B","key":"1949_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.freeradbiomed.2015.03.030","volume":"88","author":"K Zimmermann","year":"2015","unstructured":"Zimmermann K, Baldinger J, Mayerhofer B, Atanasov AG, Dirsch VM, Heiss EH. Activated AMPK boosts the Nrf2\/HO-1 signaling axis\u2013A role for the unfolded protein response. Free Radic Biol Med. 2015;88(Pt B):417\u201326.","journal-title":"Free Radic Biol Med"},{"key":"1949_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01949-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01949-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01949-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:33:45Z","timestamp":1700285625000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01949-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01949-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The American National Institutes of Health\u2019s ''Guidelines for the Management and Use of Experimental Animals'' were followed when using animals and conducting the experiment. The Animal Ethics Committee at Nankai University gave its consent to all animal procedures on February 27, 2021 (approval number: 2021-SYDWLL-000003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}